Weill Cornell Researchers Receive $1.35 Million to Advance Prostate Cancer Research
Six early-career investigators at Weill Cornell Medicine have been awarded Young Investigator Awards from the Prostate Cancer Foundation (PCF), totaling $1.35 million in research funding. These grants, ranging from $225,000 over three years, will support innovative projects aimed at understanding the molecular mechanisms of prostate cancer, discovering novel therapies, and improving patient outcomes.
Unlocking the Molecular Mysteries of Prostate Cancer
The research projects span a diverse range of approaches, reflecting the complexity of prostate cancer. Several focus on overcoming treatment resistance, a major challenge in managing advanced disease. Dr. Cheuk Man Cherie Au, for example, is developing a novel “molecular glue” that destroys the androgen receptor – a key driver of prostate cancer growth – even in forms of the disease that have become resistant to traditional hormone therapies.
Other researchers are exploring the role of metabolism in cancer progression. Dr. Silvia Rodrigues will investigate how fat metabolism influences the ability of prostate cancer cells to adapt and become resistant to treatment, potentially opening new avenues for therapeutic intervention.
Improving Patient Care Through Personalized Approaches
The awards aren’t solely focused on laboratory research. Dr. Bashir Al Hussein Al Awamlh is addressing a critical issue in patient care: health literacy. His project aims to develop web-based programs and peer coaching to help men with advanced prostate cancer navigate their diagnosis, understand their treatment options, and adhere to their care plans. Low health literacy is linked to poorer outcomes, increasing mortality rates by two to three-fold.
Dr. Kevin Kensler’s research explores the potential impact of anti-obesity and diabetes medications – GLP-1 receptor agonists and SGLT2 inhibitors – on prostate cancer risk and outcomes. This research could lead to improved management of both the cancer and the metabolic health of patients undergoing hormone therapy.
New Insights into Metastasis and Genetic Factors
Understanding how prostate cancer spreads (metastasizes) is crucial for developing effective treatments. Dr. Lise Brault is using a novel “recordable barcode” technology to track the evolution of metastatic cancer cells under therapeutic pressure, hoping to identify vulnerabilities that can be exploited with new therapies.
Dr. Xuanrong Chen is investigating the role of a DNA repair protein, MBD4, in regulating androgen receptor activity and driving prostate cancer development. His operate using organoids – simplified organs grown in the lab – could lead to new ways to manipulate this relationship and improve treatment strategies.
The PCF’s Commitment to Innovation
These awards are part of the Prostate Cancer Foundation’s Class of 2025 Young Investigators, a group of thirty-one researchers selected from across the country. The PCF has been a leading force in prostate cancer research since 1993, working to finish death and suffering from the disease.
Did you grasp?
Prostate cancer is one of the most common cancers in the Western hemisphere, highlighting the importance of continued research and innovation.
Frequently Asked Questions
- What is the goal of the PCF Young Investigator Awards? These awards aim to energize the field of prostate cancer research with fresh ideas from postdoctoral fellows and early-career faculty.
- How much funding is being awarded to Weill Cornell Medicine? Weill Cornell Medicine researchers are receiving a total of $1.35 million through these awards.
- What is health literacy and why is it important in prostate cancer care? Health literacy is the ability to find and act on health-related information. Low health literacy can significantly worsen outcomes for prostate cancer patients.
- What are organoids and how are they used in research? Organoids are simplified organs grown in the lab, used to study disease mechanisms and test potential therapies.
Learn more about prostate cancer research and support at the Prostate Cancer Foundation website.
Explore treatment options and clinical trials at the Weill Cornell Medicine Multidisciplinary Prostate Cancer Clinic.
Worth a look